Synthetic Strategy and Anti-Tumor Activities of Macrocyclic Scaffolds Based on 4-Hydroxyproline
A series of novel 13- to 15-member hydroxyproline-based macrocycles, which contain alkyl-alkyl ether and alkyl-aryl ether moieties, have been synthesized by the strategy of macrocyclization utilising azide-alkyne cycloaddition, Mitsunobu protocol and amide formation. Their anti-tumor activities towa...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-02-01
|
Series: | Molecules |
Subjects: | |
Online Access: | http://www.mdpi.com/1420-3049/21/2/212 |
id |
doaj-528b113d9f254525aeb84c79a4c4cc24 |
---|---|
record_format |
Article |
spelling |
doaj-528b113d9f254525aeb84c79a4c4cc242020-11-24T22:16:54ZengMDPI AGMolecules1420-30492016-02-0121221210.3390/molecules21020212molecules21020212Synthetic Strategy and Anti-Tumor Activities of Macrocyclic Scaffolds Based on 4-HydroxyprolineGuorui Cao0Kun Yang1Yue Li2Longjiang Huang3Dawei Teng4College of Chemical Engineering, Qingdao University of Science and Technology, Qingdao 266042, ChinaCollege of Chemical Engineering, Qingdao University of Science and Technology, Qingdao 266042, ChinaCollege of Chemical Engineering, Qingdao University of Science and Technology, Qingdao 266042, ChinaCollege of Chemical Engineering, Qingdao University of Science and Technology, Qingdao 266042, ChinaCollege of Chemical Engineering, Qingdao University of Science and Technology, Qingdao 266042, ChinaA series of novel 13- to 15-member hydroxyproline-based macrocycles, which contain alkyl-alkyl ether and alkyl-aryl ether moieties, have been synthesized by the strategy of macrocyclization utilising azide-alkyne cycloaddition, Mitsunobu protocol and amide formation. Their anti-tumor activities towards A549, MDA-MB-231 and Hep G2 cells were screened in vitro by an MTT assay. The results indicated that 13-member macrocycle 33 containing alkene chain showed the best results, exhibiting the highest inhibitory effects towards lung cancer cell line A549, which was higher than that of the reference cisplatin (IC50 value = 2.55 µmol/L).http://www.mdpi.com/1420-3049/21/2/212macrocycle4-hydroxyprolineazide-alkyne cycloadditionMitsunobu reactionamide formationanti-tumor activity |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Guorui Cao Kun Yang Yue Li Longjiang Huang Dawei Teng |
spellingShingle |
Guorui Cao Kun Yang Yue Li Longjiang Huang Dawei Teng Synthetic Strategy and Anti-Tumor Activities of Macrocyclic Scaffolds Based on 4-Hydroxyproline Molecules macrocycle 4-hydroxyproline azide-alkyne cycloaddition Mitsunobu reaction amide formation anti-tumor activity |
author_facet |
Guorui Cao Kun Yang Yue Li Longjiang Huang Dawei Teng |
author_sort |
Guorui Cao |
title |
Synthetic Strategy and Anti-Tumor Activities of Macrocyclic Scaffolds Based on 4-Hydroxyproline |
title_short |
Synthetic Strategy and Anti-Tumor Activities of Macrocyclic Scaffolds Based on 4-Hydroxyproline |
title_full |
Synthetic Strategy and Anti-Tumor Activities of Macrocyclic Scaffolds Based on 4-Hydroxyproline |
title_fullStr |
Synthetic Strategy and Anti-Tumor Activities of Macrocyclic Scaffolds Based on 4-Hydroxyproline |
title_full_unstemmed |
Synthetic Strategy and Anti-Tumor Activities of Macrocyclic Scaffolds Based on 4-Hydroxyproline |
title_sort |
synthetic strategy and anti-tumor activities of macrocyclic scaffolds based on 4-hydroxyproline |
publisher |
MDPI AG |
series |
Molecules |
issn |
1420-3049 |
publishDate |
2016-02-01 |
description |
A series of novel 13- to 15-member hydroxyproline-based macrocycles, which contain alkyl-alkyl ether and alkyl-aryl ether moieties, have been synthesized by the strategy of macrocyclization utilising azide-alkyne cycloaddition, Mitsunobu protocol and amide formation. Their anti-tumor activities towards A549, MDA-MB-231 and Hep G2 cells were screened in vitro by an MTT assay. The results indicated that 13-member macrocycle 33 containing alkene chain showed the best results, exhibiting the highest inhibitory effects towards lung cancer cell line A549, which was higher than that of the reference cisplatin (IC50 value = 2.55 µmol/L). |
topic |
macrocycle 4-hydroxyproline azide-alkyne cycloaddition Mitsunobu reaction amide formation anti-tumor activity |
url |
http://www.mdpi.com/1420-3049/21/2/212 |
work_keys_str_mv |
AT guoruicao syntheticstrategyandantitumoractivitiesofmacrocyclicscaffoldsbasedon4hydroxyproline AT kunyang syntheticstrategyandantitumoractivitiesofmacrocyclicscaffoldsbasedon4hydroxyproline AT yueli syntheticstrategyandantitumoractivitiesofmacrocyclicscaffoldsbasedon4hydroxyproline AT longjianghuang syntheticstrategyandantitumoractivitiesofmacrocyclicscaffoldsbasedon4hydroxyproline AT daweiteng syntheticstrategyandantitumoractivitiesofmacrocyclicscaffoldsbasedon4hydroxyproline |
_version_ |
1725787761920704512 |